While actions taken against certain FinTech players, I think it's a very clear message to all NBFCs to clean up their books and get their acts together ...
As the second oral therapy approved by the U.S. Food and Drug Administration (FDA) for the treatment of Alzheimer’s disease during the past decade, ZUNVEYL demonstrates a potentially better safety ...